Notrixum

Notrixum

atracurium besilate

Manufacturer:

Novell Pharma

Distributor:

DKLL

Marketer:

Genemax Healthcare
Concise Prescribing Info
Contents
Atracurium besylate
Indications/Uses
Adjunct to general anesth to facilitate endotracheal intubation & to relax skeletal muscles during surgery; to facilitate mechanical ventilation in ICU patients.
Dosage/Direction for Use
Adult IV 0.3-0.6 mg/kg. Endotracheal intubation 0.5-0.6 mg/kg. Full block prolongation 0.1-0.2 mg/kg. IV infusion After an initial 0.3-0.6 mg/kg bolus dose, neuromuscular block may be maintained by administration of 0.3-0.6 mg/kg/hr as continuous infusion. ICU patients Maintenance of neuromuscular block: 11-13 mcg/kg/min.
Special Precautions
History of hypersensitivity reactions. Myasthenia gravis, other forms of neuromuscular disease & severe electrolyte imbalance; hypovolemia, burns. Pregnancy & lactation.
Adverse Reactions
Skin flushing, mild transient hypotension or bronchospasm.
Drug Interactions
Avoid concomitant use w/ quinine. Increased effect w/ abobotulinum toxin A, aminoglycosides, Ca channel blockers, capreomycin, colistimethate, inhalational anesth, ketorolac, lincosamide, lithium, loop diuretics, Mg salts, polymyxin B, procainamide; quinidine, quinine, spironolactone, tetracycline derivatives, vancomycin.
ATC Classification
M03AC04 - atracurium ; Belongs to the class of other quaternary ammonium-containing agents used as peripherally-acting muscle relaxants.
Presentation/Packing
Form
Notrixum soln for inj 10 mg/mL
Packing/Price
2.5 mL x 5 × 1's;5 mL x 5 × 1's
/thailand/image/info/notrixum soln for inj 10 mg-ml/10 mg x 2-5 ml?id=20998eec-2f66-401b-841c-ac4101215aec
/thailand/image/info/notrixum soln for inj 10 mg-ml/10 mg x 5 ml?id=d42eeeae-879b-4974-bc3b-ac4101215aec
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in